Book Cover
Home  |   Healthcare   |  Nasogastric Tube Market

Nasogastric Tube Market Size, Share, Growth, and Industry Analysis, By Type (Levin tube, Sengstaken-Blakemore tube, Others), By Application (Children Use, Adult Use), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US

Nasogastric Tube Market Overview

The global Nasogastric Tube Market size estimated at USD 317.6 million in 2026 and is projected to reach USD 441.38 million by 2035, growing at a CAGR of 3.72% from 2026 to 2035.

Metric Value
Largest region North America (39.3%)
Largest application Adult Use (73.8%)
Largest type Levin tube (50.1%)
Fastest-moving product trend Flexible, radiopaque nasogastric tubes with standardized enteral connectors and improved placement safety
Leading companies BD (5%), Cardinal Health (21.3%)

The Nasogastric Tube Market is experiencing sustained demand as healthcare providers increasingly prioritize effective gastrointestinal management, enteral nutrition, medication administration, and gastric decompression. Nasogastric tubes are widely used across emergency departments, intensive care units, surgical wards, and long-term care facilities to support patients unable to maintain adequate oral intake or requiring removal of gastric contents. Levin tubes represent approximately 50.1% of product demand in the referenced 2026 market estimates, reflecting their established clinical applications and relatively simple construction. Manufacturers are improving tube flexibility, radiopaque visibility, secure connectors, and patient comfort through advanced materials and specialized designs. The growing burden of swallowing disorders, neurological conditions, gastrointestinal diseases, and postoperative recovery requirements is reinforcing recurring demand. Healthcare facilities are increasingly evaluating product safety, material compatibility, infection prevention, and clinical handling efficiency when selecting nasogastric tube systems.

The United States remains a significant contributor to the Nasogastric Tube Market, supported by an extensive healthcare network comprising approximately 6,100 hospitals and established emergency, critical care, and surgical infrastructure. Demand is concentrated in hospitals treating patients requiring temporary nutritional support, gastric aspiration, and gastrointestinal decompression. Adult Use represents approximately 73.8% of the global patient-based application mix in the referenced estimates, illustrating the importance of adult medical and surgical care. Healthcare institutions are increasingly adopting standardized tube placement protocols, radiopaque devices, and compatible feeding connectors to strengthen patient safety. Manufacturers including BD and Cardinal Health offer nasogastric products in multiple French sizes to address changing patient requirements. Increasing attention to dysphagia management, clinical nutrition, and safe placement verification is expected to support continued product adoption throughout the forecast period.

Global Nasogastric Tube Market Size, 2035 (USD Million)

Get Comprehensive Insights into the Market’s Size and Growth Trends

downloadDownload FREE Sample

Key Findings

  • Market Driver: Increasing requirements for enteral nutrition and gastric decompression are supporting market growth, with Adult Use accounting for approximately 73.8% of patient-based demand due to extensive medical, surgical, and critical care applications.
  • Major Market Restraint: Placement complications, clinical verification requirements, and specialized nursing procedures influence adoption, while approximately 26.2% of patient-based demand involves children requiring particularly careful tube sizing, positioning, and monitoring.
  • Emerging Trends: Manufacturers are emphasizing softer materials, radiopaque visibility, improved connectors, and placement support, while Levin tubes represent approximately 50.1% of product demand, encouraging continued development of versatile and clinically practical devices.
  • Regional Leadership: North America leads the Nasogastric Tube Market with approximately 39.3% market share, supported by developed hospital infrastructure, established clinical nutrition practices, specialized healthcare services, and widespread availability of gastrointestinal medical devices.
  • Competitive Landscape: BD maintains a prominent competitive position through its nasogastric tube portfolio, including 18F configurations featuring radiopaque markings, specialized connectors, and stabilization components designed to address different clinical requirements.
  • Market Segmentation: Levin tube leads the supplied product categories with approximately 50.1% market share, while Adult Use dominates patient applications through widespread demand for gastrointestinal decompression, enteral nutrition, and postoperative management.
  • Recent Development: In September 2026, GBUK Group announced a pediatric nasogastric tube procurement agreement, with the contract beginning on August 1, supporting broader institutional access to feeding tubes and related clinical accessories.

The Nasogastric Tube Market is witnessing growing interest in patient-friendly tubing materials, standardized enteral connectors, and technologies supporting more reliable placement. Hospitals increasingly prefer flexible products with radiopaque markings, durable construction, and secure attachment features that improve clinical handling. Levin tubes account for approximately 50.1% of product demand, encouraging manufacturers to enhance established designs while developing specialized alternatives. Product differentiation increasingly depends on insertion characteristics, compatibility with clinical workflows, and suitability for different patient groups.

Another important trend is the development of pediatric-focused feeding solutions and improved tube-position verification. Children Use represents approximately 26.2% of patient-based demand, encouraging manufacturers to introduce smaller dimensions, carefully designed connectors, and suitable securement products. Healthcare facilities are also evaluating imaging-assisted verification, standardized procedures, and improved documentation to reduce placement-related risks. Demand for integrated feeding systems is encouraging greater attention to tube construction, accessory compatibility, and clinician training.

Market Dynamics

Driver

"Rising demand for enteral nutrition and gastrointestinal care supports market expansion."

Increasing requirements for enteral nutrition, medication administration, and gastric decompression represent major growth drivers in the Nasogastric Tube Market. Patients experiencing swallowing impairment, neurological disorders, gastrointestinal obstruction, and postoperative complications frequently require temporary gastric access. Adult Use accounts for approximately 73.8% of patient-based demand, supported by extensive applications across critical care, surgery, and medical rehabilitation. Growing clinical emphasis on maintaining nutritional intake during recovery is sustaining demand for reliable and appropriately sized nasogastric tubes.

Expansion of hospital services and improvements in critical care management are further strengthening product adoption. Healthcare providers require dependable tubing systems for short-term feeding, aspiration, and gastrointestinal decompression across diverse patient populations. Levin tubes hold an estimated 50.1% product share because of their familiar design and suitability for commonly performed gastric procedures. Manufacturers are focusing on consistent product quality, secure connectors, and compatibility with established clinical protocols to maintain demand.

Restraint

"Placement safety requirements and patient discomfort limit wider clinical adoption."

Incorrect positioning, nasal irritation, aspiration risks, and accidental tube displacement remain important restraints affecting the Nasogastric Tube Market. Healthcare professionals must verify appropriate tube placement before using devices for feeding or medication administration, increasing procedural responsibilities. Children Use accounts for approximately 26.2% of patient-based demand, emphasizing the importance of patient-specific sizing and careful monitoring. Concerns regarding clinical complications can influence institutional purchasing decisions and increase demand for enhanced safety features.

Additional constraints include replacement requirements, staff training, connector compatibility, and challenges associated with prolonged nasal access. Hospitals often manage multiple tube sizes and configurations, creating inventory complexity and requiring standardized procedures. Common adult configurations include 12F, 14F, 16F, and 18F tubing, with selection depending on the clinical indication and manufacturer instructions. Manufacturers are responding through improved materials, placement visibility, securement devices, and clearer product identification to support safer clinical workflows.

Opportunity

"Advanced materials and pediatric feeding solutions create new growth opportunities."

Development of flexible, biocompatible, and placement-assisted nasogastric tubes creates opportunities for manufacturers seeking differentiation in hospital procurement. Advanced radiopaque markings, secure connection systems, and patient-friendly materials can improve clinical usability and product acceptance. North America represents approximately 39.3% of market demand, providing a substantial established healthcare market for specialized tube solutions. Manufacturers investing in reliable designs and improved handling characteristics can address increasing expectations surrounding patient comfort and procedural safety.

Emerging healthcare markets also offer opportunities through expanding critical care capacity, hospital modernization, and improved access to clinical nutrition. Asia-Pacific contributes approximately 27.2% of global demand, reflecting an important regional base for affordable and standardized medical products. Pediatric-focused manufacturing represents another opportunity because smaller tube dimensions require careful material selection, flexibility, and connection design. Companies offering dependable products across different patient sizes can strengthen their positions through institutional partnerships and distribution expansion.

Challenge

"Manufacturing consistency and clinical compatibility create operational challenges."

Maintaining consistent tube performance while improving patient comfort represents a significant technical challenge for nasogastric tube manufacturers. Devices must provide adequate flexibility while resisting kinking, disconnection, and structural failure during clinical use. Product portfolios commonly include 8F, 10F, 12F, 14F, 16F, and 18F configurations, requiring precise dimensional control and manufacturing consistency. Additional features such as radiopaque stripes, specialized connectors, and stabilization components can increase production complexity and testing requirements.

Manufacturers must also navigate medical device regulations, sterilization requirements, packaging integrity, and hospital procurement standards across multiple regions. Differences in clinical protocols and connector systems can complicate international distribution and product standardization. ENFit-compatible systems follow ISO 80369-3 specifications intended to reduce misconnections involving enteral devices. Companies must balance regulatory compliance, dependable supply, clinical performance, and production efficiency while supporting changing healthcare requirements.

Segmentation Analysis

Global Nasogastric Tube Market Size, 2035

Get Comprehensive Insights on the Market Segmentation in this Report

download Download FREE Sample

By Types

Levin tube: Levin tubes account for approximately 50.1% of the Nasogastric Tube Market, making them the leading supplied product type. Their established clinical role is supported by relatively straightforward construction, convenient handling, and compatibility with common gastric procedures. Levin tubes are used for gastric decompression, aspiration, and other clinically appropriate applications depending on device specifications. Hospitals frequently select these products because medical professionals are familiar with their general operating characteristics. The availability of different French sizes supports usage across varied patient needs, while radiopaque markings and suitable connector arrangements improve practical functionality. Continued demand from emergency departments, surgical wards, and gastrointestinal services supports the category's leading position in the supplied segmentation.

Manufacturers are improving Levin tube designs through material refinement, dimensional consistency, and features intended to support secure placement and clinical handling. Products may be manufactured using medical-grade polymers selected according to flexibility, transparency, durability, and intended use. A diameter conversion of 1 French to approximately 0.33 millimeters helps clinicians interpret tube sizing, although product choice depends on patient condition and clinical protocols. Increasing emphasis on careful insertion, placement confirmation, and documentation is influencing procurement decisions. Demand for familiar and cost-conscious designs remains significant in hospitals managing recurring short-term gastric procedures. Innovation therefore focuses on practical improvements that support reliability without introducing unnecessary complexity into established clinical workflows.

Sengstaken-Blakemore tube: Sengstaken-Blakemore tubes represent a specialized category within the Nasogastric Tube Market, primarily associated with emergency management of severe upper gastrointestinal bleeding in carefully selected patients. Unlike conventional single-lumen designs, these devices incorporate balloon-based mechanisms and multiple functional channels. Their use is considerably more specialized than routine enteral feeding or gastric decompression because placement and operation require experienced clinicians and intensive monitoring. The category does not have a sufficiently reliable standalone 2026 global share in the accessible market breakdown, and assigning an exact percentage would be speculative. Demand is concentrated in facilities capable of managing complex gastrointestinal emergencies and providing appropriate critical care support.

Clinical requirements for Sengstaken-Blakemore tubes emphasize structural reliability, controlled balloon inflation, clear component identification, and consistent manufacturing quality. Traditional designs use separate gastric and esophageal balloon functions to provide temporary mechanical control of selected bleeding complications. These products are generally considered temporary emergency interventions rather than routine feeding devices. Manufacturers must address specialized handling requirements, packaging integrity, and dependable material performance. Although the category serves a comparatively limited clinical population, it remains relevant to hospitals requiring emergency gastrointestinal equipment. Greater availability of alternative endoscopic and interventional treatments influences demand, making appropriate patient selection and clinical training important purchasing considerations.

Others: The Others category includes specialized nasogastric designs and configurations not classified as Levin tube or Sengstaken-Blakemore tube within the supplied segmentation. Using the estimated 50.1% Levin share, the combined remaining allocation for Sengstaken-Blakemore tube and Others is 49.9%, but the accessible data do not independently establish their individual shares. Products within this broader category may address specific requirements involving gastric drainage, short-term nutritional administration, or enhanced clinical handling. Hospitals increasingly evaluate specialized tube designs according to material properties, patient tolerance, radiopaque visibility, and connection compatibility. Demand is influenced by the complexity of clinical procedures and the need for more tailored gastrointestinal access solutions.

Manufacturers operating within the Others category are focusing on improved flexibility, secure connectors, and components intended to support consistent tube positioning. Specialized sump-type configurations, for example, can incorporate an additional venting function to support gastric decompression when clinically indicated. Products may also include features such as radiopaque markings, anti-reflux components, and standardized enteral connectors. The wider product category provides opportunities for innovation because hospitals require devices suited to different clinical procedures and patient populations. Increasing focus on patient comfort and procedural efficiency encourages suppliers to develop differentiated solutions. Maintaining reliable performance across specialized designs remains essential as healthcare facilities prioritize safety, product availability, and clinical compatibility.

By Applications

Children Use: Children Use accounts for approximately 26.2% of the Nasogastric Tube Market according to the referenced patient-based segmentation. Pediatric patients may require nasogastric access for nutritional support, medication administration, gastrointestinal decompression, and selected clinical procedures. Neonatal and pediatric care settings demand particular attention to tube dimensions, material softness, positioning, and securement because anatomical requirements differ from those of adults. Smaller tube sizes are often necessary, and healthcare professionals must consider age, weight, clinical condition, and prescribed treatment. Manufacturers are improving pediatric products through flexible materials, clearly identified connectors, and designs intended to reduce handling difficulties. Growing attention to nutritional management in children with feeding challenges supports continued demand for appropriately designed products.

Pediatric nasogastric tube development increasingly emphasizes secure placement, gentle materials, and compatibility with hospital feeding systems. Healthcare providers require reliable solutions that can support accurate medication delivery and nutritional administration while minimizing the risk of dislodgement. Small-bore options, including 6F and 8F configurations where clinically appropriate, illustrate the importance of patient-specific product selection. Specialized stabilization products and documented position checks further support safe clinical practice. Manufacturers supplying pediatric devices must meet demanding quality expectations while maintaining accessible product availability. Hospitals also value training support, standardized packaging, and connection compatibility because pediatric tube management requires careful monitoring and coordinated clinical procedures.

Adult Use: Adult Use dominates the Nasogastric Tube Market with approximately 73.8% of patient-based demand, supported by extensive applications in hospitals, emergency departments, surgical wards, and critical care facilities. Adults may require temporary gastric access because of swallowing difficulties, neurological disorders, postoperative gastrointestinal dysfunction, or conditions affecting normal oral intake. Nasogastric tubes can support enteral nutrition, medication administration, and gastric decompression when appropriate to the clinical indication. Hospitals maintain access to multiple product configurations to address differing requirements across medical and surgical specialties. The substantial adult patient population contributes to recurring product demand and supports institutional procurement of standardized devices.

Adult nasogastric tube usage is also influenced by population aging, complex chronic conditions, and increasing attention to clinical nutrition during hospitalization. Products are available in multiple French sizes, including 12F, 14F, 16F, and 18F configurations, although selection must be individualized. Healthcare professionals evaluate tube purpose, required flow characteristics, material suitability, and placement confirmation before clinical use. Manufacturers are developing radiopaque tubing, secure connectors, and stabilization accessories to improve procedural management. The adult segment is expected to remain the leading application category because gastric access continues to be important in diverse clinical settings. Ongoing efforts to improve patient safety and nursing efficiency will influence product preferences throughout the forecast period.

Regional Outlook

Global Nasogastric Tube Market Share, by Type 2035

Get Comprehensive Insights into the Market’s Size and Growth Trends

download Download FREE Sample

North America

North America leads the Nasogastric Tube Market with approximately 39.3% market share in the referenced 2026 estimates, supported by advanced hospital infrastructure, extensive critical care services, and established gastrointestinal treatment practices. The United States represents a major contributor, with approximately 6,100 hospitals providing a substantial institutional base for medical device demand. Healthcare providers require nasogastric tubes for enteral nutrition, gastric decompression, medication administration, and postoperative management. Increasing attention to swallowing disorders, nutritional support, and patient safety encourages product adoption across medical and surgical departments. Manufacturers including BD and Cardinal Health maintain relevant tube portfolios serving regional clinical requirements. Hospitals are also emphasizing secure connectors, radiopaque visibility, and standardized placement procedures to support reliable care.

Europe

Europe represents an important regional market for nasogastric tubes because of established healthcare systems, aging populations, specialized hospital services, and increasing attention to nutritional management. The region forms part of the remaining 33.5% global allocation after the separately reported North American and Asia-Pacific shares; an independently verified European percentage is not available in the accessible breakdown. Hospitals require nasogastric access for patients experiencing swallowing impairment, gastrointestinal complications, and temporary nutritional difficulties. Manufacturers are focusing on product traceability, connector compatibility, patient safety, and compliance with medical device regulations. Healthcare providers are also evaluating flexible materials and standardized feeding components to improve clinical performance. Growing demand for safe enteral nutrition and dependable gastrointestinal devices is expected to support continued regional adoption.

Asia-Pacific

Asia-Pacific accounts for approximately 27.2% of the Nasogastric Tube Market, supported by expanding healthcare infrastructure, hospital modernization, and increasing demand for medical nutrition and gastrointestinal treatment. Countries across the region are strengthening critical care facilities, surgical services, and access to essential medical devices. Growing patient populations and improvements in hospital capacity are creating opportunities for manufacturers offering clinically reliable and affordable tubing systems. Regional demand includes both Children Use and Adult Use, requiring products available in suitable sizes and configurations. Companies including Guangdong Baihe Medical Technology and Pacific Hospital Supply participate in medical device supply chains relevant to these requirements. Improvements in distribution networks, quality standards, and clinical training are expected to strengthen market accessibility.

Middle East and Africa

The Middle East and Africa region is developing opportunities within the Nasogastric Tube Market through healthcare infrastructure investment, expanding hospital capacity, and growing demand for essential gastrointestinal medical devices. Together with Europe and Rest of the World, the region falls within the 33.5% allocation not separately assigned to North America and Asia-Pacific in the accessible estimates. Healthcare providers require dependable nasogastric equipment for intensive care, surgical recovery, nutritional support, and selected emergency procedures. Demand is supported by modernization of medical facilities and improvements in professional healthcare services. Manufacturers can address regional requirements through durable products, appropriate sizing, consistent quality, and accessible distribution partnerships. Investment in training, clinical safety, and dependable supplies is expected to influence future adoption.

Rest of the World

Rest of the World markets present gradual growth opportunities as developing healthcare systems improve access to essential medical devices and gastrointestinal treatment services. The accessible regional estimates identify 39.3% for North America and 27.2% for Asia-Pacific but do not separately quantify Rest of the World demand. Hospitals and clinics increasingly require reliable nasogastric tubes for temporary enteral nutrition, aspiration, medication administration, and gastrointestinal decompression. Manufacturers can strengthen regional availability through local distributors, standardized product configurations, and improved medical supply networks. Cost-conscious purchasing remains important, particularly where clinical infrastructure and specialist support are still developing. Increasing awareness of patient safety, appropriate tube placement, and nutritional management should support long-term opportunities across these markets.

List of Top Nasogastric Tube Market Companies

  • BD
  • Cardinal Health
  • Guangdong Baihe Medical Technology
  • Andersen Products
  • Q Holding Company
  • GBUK Group Ltd.
  • Rontis
  • Bicakcilar
  • Pacific Hospital Supply

Top 2 Companies with Highest Market Share

  • BD: BD is a leading participant in the global Nasogastric Tube Market, supported by its established medical device portfolio, extensive hospital distribution network, and advanced gastrointestinal care solutions. A related market study identifies Bard Medical, associated with BD, as holding approximately 5% of global nasogastric tube market share. 
  • Cardinal Health: Cardinal Health maintains a strong competitive position through its extensive gastrointestinal medical product portfolio, established healthcare partnerships, and broad institutional distribution network. A separate medical nasogastric feeding tube market study estimates its share at approximately 21.3%. 

Investment Analysis and Opportunities

Investment opportunities in the Nasogastric Tube Market are increasingly concentrated in product safety, advanced medical materials, manufacturing efficiency, and hospital distribution. North America accounts for approximately 39.3% of estimated global demand, providing an established market for specialized medical devices and improved clinical systems. Manufacturers are investing in radiopaque tubing, secure connectors, flexible materials, and placement-support technologies to meet changing institutional requirements. Opportunities also exist in manufacturing automation and quality control, which can improve dimensional accuracy, product consistency, and dependable availability across hospitals.

Asia-Pacific represents approximately 27.2% of market demand, creating opportunities for regional production, distribution expansion, and accessible clinical nutrition products. Pediatric solutions are particularly relevant because Children Use accounts for approximately 26.2% of patient-based demand. Investment in smaller tube configurations, securement devices, and standardized feeding connections can address specialized healthcare requirements. Manufacturers that combine regulatory compliance, cost efficiency, and dependable product performance may strengthen their positions through long-term institutional supply partnerships.

New Product Development

New product development in the Nasogastric Tube Market emphasizes flexible materials, reliable placement visibility, and improved safety during clinical use. Manufacturers are refining tubing construction through radiopaque markings, securement accessories, specialized valves, and patient-appropriate dimensions. Levin tubes account for approximately 50.1% of the supplied product market, encouraging manufacturers to improve commonly used designs while addressing specific clinical requirements. Product innovation is increasingly focused on compatibility with hospital feeding equipment, convenient handling, and consistent manufacturing quality.

Pediatric-focused innovation is another important area as manufacturers develop tubing systems suitable for children requiring nutritional support and gastrointestinal care. Children Use accounts for approximately 26.2% of patient-based demand, supporting development of smaller, more flexible medical devices. Product configurations may include narrow-bore tubes, clearly identified connectors, radiopaque markers, and compatible fixation products. Manufacturers are also evaluating placement-assistance technologies and improved verification workflows to support clinicians. Continued development in material performance and connector standardization is expected to influence product differentiation.

Five Recent Developments

Date Company Development
September 2026 GBUK Group Ltd. GBUK Group announced its Vizient MS 1559 contract for pediatric nasogastric products, effective August 2026. The agreement provides an institutional procurement route for feeding tubes, extension sets, drainage products, and placement-related accessories.
October 2026 BD The company's publicly documented portfolio includes 12F, 14F, 16F, and 18F configurations with features supporting gastric decompression and securement. This is a current portfolio observation, not a verified October product launch.
October 2026 Cardinal Health The company's established gastrointestinal product portfolio includes Levin-type tubes and selected 8F nasogastric configurations relevant to institutional procurement. This entry reflects documented product availability rather than a verified October announcement.
October 2026 Guangdong Baihe Medical Technology Guangdong Baihe Medical Technology remains among the listed manufacturers serving the nasogastric tube sector. Its current competitive relevance concerns medical device manufacturing and hospital supply; a distinct October 2026 launch was not independently verified.
October 2026 Pacific Hospital Supply Pacific Hospital Supply remains a listed participant in the medical tubing sector, supporting the wider competitive environment for hospital consumables. No independently confirmed October 2026 product introduction or quantified expansion was established.

Future Outlook

The Nasogastric Tube Market is expected to experience steady development through 2035, supported by increasing demand for clinical nutrition, gastrointestinal care, and dependable medical tubing products. Levin tubes, holding approximately 50.1% of the supplied product market, are expected to maintain their leading position through widespread hospital applications. Manufacturers will continue focusing on flexible materials, radiopaque visibility, secure connectors, and improved placement-related safety features. Growing demand for specialized pediatric products, reliable medical supplies, and efficient clinical workflows will create opportunities for product innovation.

North America is expected to retain regional leadership with approximately 39.3% market share, supported by established hospitals, advanced critical care services, and strong clinical nutrition requirements. Adult Use, representing approximately 73.8% of patient-based demand, will remain the dominant application segment. Companies including BD, Cardinal Health, GBUK Group Ltd., and Guangdong Baihe Medical Technology are positioned to address changing requirements through product availability and clinical compatibility. Healthcare infrastructure investment, safety improvements, and standardized enteral equipment will influence long-term market development.

Nasogastric Tube Market Report Coverage

REPORT COVERAGE DETAILS

Market Size Value In

USD 317.6 Million in 2026

Market Size Value By

USD 441.38 Million by 2035

Growth Rate

CAGR of 3.72% from 2026-2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type :

  • Levin tube
  • Sengstaken-Blakemore tube
  • Others

By Application :

  • Children Use
  • Adult Use

To Understand the Detailed Market Report Scope & Segmentation

download Download FREE Sample

Frequently Asked Questions

The global Nasogastric Tube Market is expected to reach USD 441.38 Million by 2035.

The Nasogastric Tube Market is expected to exhibit a CAGR of 3.72% by 2035.

BD, Cardinal Health, Guangdong Baihe Medical Technology, Andersen Products, Q Holding Company, GBUK Group Ltd., Rontis, Bicakcilar, Pacific Hospital Supply

In 2026, the Nasogastric Tube Market is estimated at USD 317.6 Million.

faq right

Our Clients

Captcha refresh

Trusted & Certified